{"@context":{"obo_purl":"http://purl.obolibrary.org/obo/","rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","owl":"http://www.w3.org/2002/07/owl#","rdfs":"http://www.w3.org/2000/01/rdf-schema#","skos":"http://www.w3.org/2004/02/skos/core#","oboinowl_gen":"http://www.geneontology.org/formats/oboInOwl#","ns0":"http://purl.obolibrary.org/obo/chebi#","metadata_def":"http://data.bioontology.org/metadata/def/","ns1":"http://purl.obolibrary.org/obo/chebi/"},"@id":"obo_purl:CHEBI_75998","@type":"owl:Class","rdfs:subClassOf":[{"@id":"obo_purl:CHEBI_24532"},{"@id":"obo_purl:CHEBI_37622"}],"rdfs:label":"trametinib","skos:notation":"CHEBI:75998","obo_purl:IAO_0000115":"A pyridopyrimidine that is used (as its dimethyl sulfoxide addition compound) for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations, and who have not received prior BRAF inhibitor treatment.","oboinowl_gen:hasExactSynonym":"N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide","oboinowl_gen:hasDbXref":["CAS:871700-17-3","Chemspider:9881833","DrugBank:DB08911","Drug_Central:4802","KEGG:D10175","LINCS:LSM-1143","PMCID:PMC7715110","PMID:21523318","PMID:22245957","PMID:23035153","PMID:23237773","PMID:23248257","PMID:23290787","PMID:23432625","PMID:23438367","PMID:23441129","PMID:23533766","PMID:23583440","PMID:23587417","PMID:23649971","PMID:23658559","PMID:23709751","PMID:23807941","PMID:23844038","PMID:23846731","PMID:23893461","PMID:23971497","PMID:23977666","PMID:24055054","PMID:26119340","PMID:33922284","PMID:34034619","PMID:34145930","PMID:34156985","PMID:34282746","PMID:34355652","PMID:34413035","PMID:34421360","PMID:34484797","PMID:34516041","PMID:34590600","PMID:34592184","Patent:WO2005121142","Patent:WO2011038082","Patent:WO2011038085","Patent:WO2011047238","Reaxys:12497153","Wikipedia:Trametinib"],"oboinowl_gen:hasOBONamespace":"chebi_ontology","oboinowl_gen:id":"CHEBI:75998","oboinowl_gen:inSubset":{"@id":"ns0:3_STAR"},"metadata_def:prefLabel":"trametinib","oboinowl_gen:hasRelatedSynonym":["GSK 1120212","JTP 74057","trametinib","trametinibum"],"metadata_def:mappingLoom":"trametinib","metadata_def:mappingSameURI":{"@id":"obo_purl:CHEBI_75998"},"ns1:charge":"0","ns1:formula":"C26H23FIN5O4","ns1:inchi":"InChI=1S/C26H23FIN5O4/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34)","ns1:inchikey":"LIRYPHYGHXZJBZ-UHFFFAOYSA-N","ns1:mass":"615.39480","ns1:monoisotopicmass":"615.07788","ns1:smiles":"CC(=O)Nc1cccc(c1)-n1c2c(C)c(=O)n(C)c(Nc3ccc(I)cc3F)c2c(=O)n(C2CC2)c1=O"}
{"@context":{"obo_purl":"http://purl.obolibrary.org/obo/","rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","owl":"http://www.w3.org/2002/07/owl#","rdfs":"http://www.w3.org/2000/01/rdf-schema#","skos":"http://www.w3.org/2004/02/skos/core#","oboinowl_gen":"http://www.geneontology.org/formats/oboInOwl#","ns0":"http://purl.obolibrary.org/obo/chebi#","metadata_def":"http://data.bioontology.org/metadata/def/","ns1":"http://purl.obolibrary.org/obo/chebi/"},"@id":"obo_purl:CHEBI_75998","@type":"owl:Class","rdfs:subClassOf":[{"@id":"obo_purl:CHEBI_24532"},{"@id":"obo_purl:CHEBI_37622"}],"rdfs:label":"trametinib","skos:notation":"CHEBI:75998","obo_purl:IAO_0000115":"A pyridopyrimidine that is used (as its dimethyl sulfoxide addition compound) for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations, and who have not received prior BRAF inhibitor treatment.","oboinowl_gen:hasExactSynonym":"N-(3-{3-cyclopropyl-5-[(2-fluoro-4-iodophenyl)amino]-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl}phenyl)acetamide","oboinowl_gen:hasDbXref":["CAS:871700-17-3","Chemspider:9881833","DrugBank:DB08911","Drug_Central:4802","KEGG:D10175","LINCS:LSM-1143","PMCID:PMC7715110","PMID:21523318","PMID:22245957","PMID:23035153","PMID:23237773","PMID:23248257","PMID:23290787","PMID:23432625","PMID:23438367","PMID:23441129","PMID:23533766","PMID:23583440","PMID:23587417","PMID:23649971","PMID:23658559","PMID:23709751","PMID:23807941","PMID:23844038","PMID:23846731","PMID:23893461","PMID:23971497","PMID:23977666","PMID:24055054","PMID:26119340","PMID:33922284","PMID:34034619","PMID:34145930","PMID:34156985","PMID:34282746","PMID:34355652","PMID:34413035","PMID:34421360","PMID:34484797","PMID:34516041","PMID:34590600","PMID:34592184","Patent:WO2005121142","Patent:WO2011038082","Patent:WO2011038085","Patent:WO2011047238","Reaxys:12497153","Wikipedia:Trametinib"],"oboinowl_gen:hasOBONamespace":"chebi_ontology","oboinowl_gen:id":"CHEBI:75998","oboinowl_gen:inSubset":{"@id":"ns0:3_STAR"},"metadata_def:prefLabel":"trametinib","oboinowl_gen:hasRelatedSynonym":["GSK 1120212","JTP 74057","trametinib","trametinibum"],"metadata_def:mappingLoom":"trametinib","metadata_def:mappingSameURI":{"@id":"obo_purl:CHEBI_75998"},"ns1:charge":"0","ns1:formula":"C26H23FIN5O4","ns1:inchi":"InChI=1S/C26H23FIN5O4/c1-13-22-21(23(31(3)24(13)35)30-20-10-7-15(28)11-19(20)27)25(36)33(17-8-9-17)26(37)32(22)18-6-4-5-16(12-18)29-14(2)34/h4-7,10-12,17,30H,8-9H2,1-3H3,(H,29,34)","ns1:inchikey":"LIRYPHYGHXZJBZ-UHFFFAOYSA-N","ns1:mass":"615.39480","ns1:monoisotopicmass":"615.07788","ns1:smiles":"CC(=O)Nc1cccc(c1)-n1c2c(C)c(=O)n(C)c(Nc3ccc(I)cc3F)c2c(=O)n(C2CC2)c1=O"}